Discussion

DR MAGGIE DINOME (Santa Monica, CA): As we have moved into the era of more personalized medicine, we are now able to tailor recommendations for treatment based on patient-specific and cancer-specific data. We have risk assessment models to determine breast cancer risk, molecular profiling tests to predict treatment benefit, and now we have an extended breast reconstruction risk assessment (BRA) score based on patient characteristics that estimates surgical risk after breast reconstruction to 1 year post-operation.
Source: Journal of the American College of Surgeons - Category: Surgery Tags: Western surgical association article Source Type: research